The University of Chicago Header Logo

Connection

Somnath Mukherjee to Time Factors

Back to Details
This is a "connection" page, showing publications Somnath Mukherjee has written about Time Factors.
Somnath Mukherjee
Connection Strength
0.022
Time Factors
  1. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 2020 12; 21(12):1574-1588.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.